{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:07:56Z","timestamp":1755223676541,"version":"3.43.0"},"reference-count":12,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2872","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:48:36Z","timestamp":1751518116000},"page":"1-4","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced efficacy of immune checkpoint inhibitors with OK\u2011432 in malignant pleural mesothelioma: A case report"],"prefix":"10.3892","volume":"23","author":[{"given":"Kazuki","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Mukai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippei","family":"Sakakibara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keima","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Fukumitsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tajiri","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Oguri","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Niimi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467\u20118601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"key20250812091834_b1-MCO-23-3-02872","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1348-0421.1967.tb00350.x","article-title":"Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci","volume":"11","author":"Okamoto","year":"1967","journal-title":"Jpn J Microbiol"},{"key":"key20250812091834_b2-MCO-23-3-02872","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1378\/chest.88.3.393","article-title":"Treatment of malignant pleural effusion","volume":"88","author":"Reshad","year":"1985","journal-title":"Chest"},{"key":"key20250812091834_b3-MCO-23-3-02872","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02170881","article-title":"Induction of endogenous tumor necrosis factor by OK-432 in ovarian cancer patients with ascites","volume":"1","author":"Mori","year":"1989","journal-title":"Biotherapy"},{"key":"key20250812091834_b4-MCO-23-3-02872","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.4049\/jimmunol.158.12.5619","article-title":"Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state","volume":"158","author":"Fujimoto","year":"1997","journal-title":"J Immunol"},{"key":"key20250812091834_b5-MCO-23-3-02872","first-page":"3917","article-title":"The past, the present and future of the OK-432 therapy for patients with malignant effusions","volume":"18","author":"Katano","year":"1998","journal-title":"Anticancer Res"},{"issue":"a028472","key":"key20250812091834_b6-MCO-23-3-02872","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028472","article-title":"Cytokines in cancer immunotherapy","volume":"10","author":"Waldmann","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"e004022","key":"key20250812091834_b7-MCO-23-3-02872","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004022","article-title":"CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1\/PD-L1 immunotherapy","volume":"10","author":"Xiao","year":"2022","journal-title":"J Immunother Cancer"},{"key":"key20250812091834_b8-MCO-23-3-02872","first-page":"3295","article-title":"Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy","volume":"24","author":"Ryoma","year":"2004","journal-title":"Anticancer Res"},{"issue":"115351","key":"key20250812091834_b9-MCO-23-3-02872","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115351","article-title":"Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma","volume":"166","author":"Sun","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"9679","key":"key20250812091834_b10-MCO-23-3-02872","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66934-6","article-title":"Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model","volume":"10","author":"Iwai","year":"2020","journal-title":"Sci Rep"},{"key":"key20250812091834_b11-MCO-23-3-02872","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jtho.2016.07.019","article-title":"Modulating immunosuppression in the intrapleural space of malignant pleural mesothelioma and predictive biomarkers to guide treatment decisions","volume":"11","author":"Wong","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"1366","key":"key20250812091834_b12-MCO-23-3-02872","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01366","article-title":"The immune microenvironment in mesothelioma: Mechanisms of resistance to immunotherapy","volume":"9","author":"Chu","year":"2019","journal-title":"Front Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:18:38Z","timestamp":1754979518000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,3]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2872","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}